Clinical Study
Baseline Comorbidities in a Population-Based Cohort of Rheumatoid Arthritis Patients Receiving Biological Therapy: Data from the Australian Rheumatology Association Database
Table 4
Self-reported infections and their severity* within the six months prior to commencing bDMARDs (n = 158).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Definitions of infection grades: Mild: activities did not change because of complaint, did not see a doctor or require prescription treatment for the complaint; Moderate: activities changed occasionally because of the complaint, saw a doctor and/or needed prescription medications to relieve the complaint; Severe: caused a major change in activities, saw a doctor, required prescription medication which only provided partial relief; if a drug treatment was responsible it may have been stopped. |